Skip to main content

Aesthetic/Cosmetic Lasers Market Worth USD 1,132.7 Million (At A CAGR Of 10.2%)

 Increasing preference for noninvasive cosmetic procedures, increasing disposable income, technological advancements, and rising medical tourism are the major drivers of the aesthetic lasers market. However, lack of reimbursement will restrain the growth of this market.

What This Report Will Provide?

Factors such as multiplatform lasers provide clinicians the flexibility and versatility of several standalone systems in a single package, and provide combination therapy to synergistically treat a single indication or provide treatment addressing multiple elements of any indication is contributing to the high growth of this segment in the forecast period.

Expected Revenue Growth:

The global aesthetic lasers market is estimated to grow at a CAGR of 10.2% during the forecast period, to reach USD 1,132.7 Million by 2021.

Major Growth Boosters:

Growing adoption of noninvasive procedures, changing lifestyles, rising incidence of skin damage, reduction in procedural costs, and rise in medical tourism devices are the major factors driving the growth of the aesthetic lasers market. However, the rising adoption of energy-based devices and low focus of market players on aesthetic/cosmetic devices are restraining the growth of this market.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94673613 

Target Audience:

  • Aesthetic/Cosmetic Lasers Manufacturers
  • Aesthetic/Cosmetic Lasers Distributors and Wholesalers
  • Various Research and Consulting Firms
  • Research Institutes
  • Contract Manufacturing Organizations (CMOS)
  • Original Equipment Manufacturers (OEMs)

Based on application, the aesthetic/cosmetic lasers type market is segmented into vascular lesions, acne & scars, pigmented lesions & tattoos, hair removal, skin rejuvenation, leg veins & varicose veins, and other applications (onychomycosis and gynecological conditions). The hair removal segment accounted for the largest share of the market due to factors such as high adoption of aesthetic procedures, developments in the laser technology, increased focus on body appearance, and high disposable income.

Based on end user, the aesthetic/cosmetic lasers type market is segmented into hospitals, private clinics, and medical spas. The private clinics segment accounted for the largest share in 2016 owing to the rising number of aesthetic/cosmetic procedures across the globe, increasing awareness about various aesthetic procedures and their benefits, growing preference of the patients for minimal invasive cosmetic surgeries, and growth in the number of private clinics and surgeons providing these treatments.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=94673613 

Regional Growth Analysis:

The market is segmented into four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Among these regional segments, North America is expected to account for the largest share of the global aesthetic lasers market. However, the Asia-pacific is expected to grow at the highest CAGR during the forecast period. The high growth in this regional segment can be attributed to factors changing lifestyles, rising incidences of skin damage, and increasing medical tourism in the region will drive the growth of this market.

Comments

Popular posts from this blog

Inspection Machines Market To Reach USD 871 Million By 2025 - Growing Demand For Personalized Medicine

  What This Report Will Provide? This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies. Expected Revenue Growth: The  Inspection machines market  is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4% during the forecast period. Major Growth Boosters: The growth of this market is majorly driven as companies are now increasingly adopting inspection systems throughout their production lines due to the growing concerns to the regulatory mandates introduced by the government and regulatory bodies in the healthcare industry to maintain compliance with Good Manufacturing Practices ( GMP ). Download PDF Brochure:    https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085   CO...

Health Information Exchange (HIE) Market Worth USD 2.0 Billion By 2025 : Growing Adoption Of EHRs

  What This Report Will Provide?  This study involved four major activities in estimating the size of the health information exchange market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. Expected Revenue Growth: [199 Pages Report]  The  global health information exchange market  is expected to reach USD 2.0 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 12.2%. Major Growth Boosters: Growth in this market can be attributed to factors such as growing need to curtail healthcare costs, focus on patient-centric care delivery, growing adoption of EHRs and other HCIT solutions, government initiatives for enhancing patient care and safety, government funding for healthcare interoperabilit...

Biologics Safety Testing Market To Reach USD 4.90 Billion By 2022 : Increasing Pharmaceutical Outsourcing

  What This Report Will Provide? Biologics are pharmaceutical products that are extracted from biological sources. Biologics safety testing is carried out by manufacturers to detect contaminants like bacterial toxins, mycoplasma, and viruses. It is a mandatory process in these companies for the quality control of raw materials as well as for process control and validation of end products. Expected Revenue Growth: The global  biologics safety testing market  is expected to reach USD 4.90 Billion by 2022 from USD 2.75 Billion in 2017, at a CAGR of 12.2% during forecast period. Major Growth Boosters: The major factors driving the growth of this market are the growth in pharmaceutical & biotechnology industry driven by government support, the positive trend of R&D investment in the life science sector, increasing number of drug launches, and high incidence & large economic burden of chronic diseases. In the coming years, emerging markets and increasing pharmaceuti...